Home » Newsletters » BioWorld Science

BioWorld Science

June 6, 2008

View Archived Issues

Acucela doses first subject in phase I age-related macular degeneration trial

Genetic cause found for X-linked rare inherited disorder causing epilepsy and mental retardation

Gene therapy slows neurological decline in children with neuronal ceroid lipofuscinosis

Protalix to commence open-label extension study for its phase III prGCD trial

Addex commences phase I interaction study with new ADX-10059 formulation

MediGene to focus R&D activities on oncology and immunology fields

GSK exercises right to AM-803 FLAP inhibitor under agreement with Amira

Santen files Japanese manufacturing and marketing approval applications for DE-089

Santen enters agreement in Japan and Asia with MacuSight for sirolimus

Addrenex completes enrollment in U.S. phase III clinical trial of Clonicel in ADHD

Avexa enters collaboration with TargetDrug for novel lead inhibitors of HCV replication

Nabi receives a USD 2.5 million milestone payment from Fresenius for CARE-2 study

Callisto commences phase I trial for constipation and IBD candidate SP-304

NIAID initiates phase I safety study of Avant's oral ETEC-Cholera vaccine

Astra Zeneca reports on novel GABA-B agonist candidate for reflux treatment

Positive first-in-human results for novel multi-CDK inhibitor PHA-848125

Kyowa Hakko and Kyorin terminate collaborative marketing agreement for Allelock

Tripep reports positive results from ongoing study of ChronVac-C HCV therapeutic vaccine

Novartis acquires Protez and North American and European rights to PZ-601 antibiotic

CHMP issues positive opinion for antibacterial agent Doribax

Emergent BioSolutions initiates phase II trial for oral typhoid vaccine candidate

Pharmacopeia identifies new lead compound for advancement under collaboration with GSK

Recent Purdue Pharma and Neuro Therapeutics patents describe novel analgesic agents

Recent Biostatin patent discloses novel agents for treating chronic wounds

New treatment options for gastrointestinal disorders described in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...